Table 1. Clinical features of the study patients (n=16), members of a single family with an Arg302Gln mutation in PRKAG2 gene.
| Patient | Sex | Age (years) | Age at onset of symptoms (years) | Sudden death | CID | LVH |
|---|---|---|---|---|---|---|
| II:8 | F | 38† | - | + | - | NA |
| II:9 | M | 40† | - | + | - | NA |
| III:23 | M | 28† | 28 | + | - | NA |
| II:5 | M | 56 | 30 | - | PM | + |
| II:6 | M | 60† | 42 | - | PM | + |
| II:7 | F | 58 | 40 | - | PM | + |
| II:10 | M | 53 | 44 | - | PM | + |
| III:8 | F | 43 | 23 | - | ICD | + |
| III:15 | M | 31 | 26 | - | PM | - |
| III:16 | F | 33 | 33 | - | - | - |
| III:18 | M | 43 | 39 | - | - | - |
| III:21 | M | 39 | 33 | - | - | + |
| III:22 | F | 35 | - | - | - | - |
| III:24 | M | 35 | - | - | - | - |
| III:27 | M | 35 | 28 | - | - | + |
| III:28 | F | 20 | - | - | - | - |
+
present; -: absent; NA: not available;
†
deceased; M: male; F: female; CID: cardiac implantable device; PM: pacemaker; ICD: implantable cardioverter-defibrillator; LVH: left ventricular hypertrophy.